Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | DiseaseId | DiseaseName | DiseaseMIM | ConceptID | Source | Typical association | HGMD variants | ClinVar variants | HGNC ID | GeneMIM |
---|
HPO disease - gene - phenotype typical associations: |
HP:0012115 | HP:0012115 | Hepatitis | 0 | ATP7A CL E G H | 538 | 198 | | | | ORPHA | 1 | | 1751 | 869 | 300011 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | C1S CL E G H | 716 | 613783 | Complement component c1s deficiency | 613783 | C3151078 | OMIM | 1 | | 388 | 1247 | 120580 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CYP7A1 CL E G H | 1581 | 209902 | | | | ORPHA | 1 | | 145 | 2651 | 118455 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CYP7B1 CL E G H | 9420 | 613812 | Bile acid synthesis defect, congenital, 3 | 613812 | C3151147 | OMIM | 1 | | 415 | 2652 | 603711 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | GLIS3 CL E G H | 169792 | 610199 | Diabetes mellitus, neonatal, with congenital hypothyroidism | 610199 | C1857775 | OMIM | 1 | | 686 | 28510 | 610192 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | GUSB CL E G H | 2990 | 584 | Al Gazali Donnai Mueller syndrome | | | ORPHA | 1 | | 414 | 4696 | 611499 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | PGM1 CL E G H | 5236 | 614921 | Congenital disorder of glycosylation type 1t | 614921 | C2752015 | OMIM | 1 | | 413 | 8905 | 171900 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | SERPINA1 CL E G H | 5265 | 60 | | | | ORPHA | 1 | | 423 | 8941 | 107400 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | SHPK CL E G H | 23729 | 440713 | | | | ORPHA | 1 | | 232 | 1492 | 605060 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | SKIV2L CL E G H | 6499 | 614602 | Trichohepatoenteric syndrome 2 | 614602 | C3281289 | OMIM | 1 | | | 10898 | 600478 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TPP2 CL E G H | 7174 | 444463 | | | | ORPHA | 1 | | 625 | 12016 | 190470 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | ATP7A CL E G H | 538 | 198 | | | | ORPHA | 1 | | 1751 | 869 | 300011 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | ATP7A CL E G H | 538 | 198 | | | | ORPHA | 1 | | 1751 | 869 | 300011 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | ATP7A CL E G H | 538 | 198 | | | | ORPHA | 1 | | 1751 | 869 | 300011 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | ATP7A CL E G H | 538 | 198 | | | | ORPHA | 1 | | 1751 | 869 | 300011 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | ATP7A CL E G H | 538 | 198 | | | | ORPHA | 1 | | 1751 | 869 | 300011 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | ATP7A CL E G H | 538 | 198 | | | | ORPHA | 1 | | 1751 | 869 | 300011 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | ATP7A CL E G H | 538 | 198 | | | | ORPHA | 1 | | 1751 | 869 | 300011 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | C1S CL E G H | 716 | 613783 | Complement component c1s deficiency | 613783 | C3151078 | OMIM | 1 | | 388 | 1247 | 120580 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | C1S CL E G H | 716 | 613783 | Complement component c1s deficiency | 613783 | C3151078 | OMIM | 1 | | 388 | 1247 | 120580 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | C1S CL E G H | 716 | 613783 | Complement component c1s deficiency | 613783 | C3151078 | OMIM | 1 | | 388 | 1247 | 120580 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | C1S CL E G H | 716 | 613783 | Complement component c1s deficiency | 613783 | C3151078 | OMIM | 1 | | 388 | 1247 | 120580 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | C1S CL E G H | 716 | 613783 | Complement component c1s deficiency | 613783 | C3151078 | OMIM | 1 | | 388 | 1247 | 120580 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | C1S CL E G H | 716 | 613783 | Complement component c1s deficiency | 613783 | C3151078 | OMIM | 1 | | 388 | 1247 | 120580 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | C1S CL E G H | 716 | 613783 | Complement component c1s deficiency | 613783 | C3151078 | OMIM | 1 | | 388 | 1247 | 120580 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | CYP7A1 CL E G H | 1581 | 209902 | | | | ORPHA | 1 | | 145 | 2651 | 118455 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | CYP7A1 CL E G H | 1581 | 209902 | | | | ORPHA | 1 | | 145 | 2651 | 118455 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | CYP7A1 CL E G H | 1581 | 209902 | | | | ORPHA | 1 | | 145 | 2651 | 118455 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | CYP7A1 CL E G H | 1581 | 209902 | | | | ORPHA | 1 | | 145 | 2651 | 118455 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | CYP7A1 CL E G H | 1581 | 209902 | | | | ORPHA | 1 | | 145 | 2651 | 118455 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | CYP7A1 CL E G H | 1581 | 209902 | | | | ORPHA | 1 | | 145 | 2651 | 118455 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | CYP7A1 CL E G H | 1581 | 209902 | | | | ORPHA | 1 | | 145 | 2651 | 118455 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | CYP7B1 CL E G H | 9420 | 613812 | Bile acid synthesis defect, congenital, 3 | 613812 | C3151147 | OMIM | 1 | | 415 | 2652 | 603711 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | CYP7B1 CL E G H | 9420 | 613812 | Bile acid synthesis defect, congenital, 3 | 613812 | C3151147 | OMIM | 1 | | 415 | 2652 | 603711 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | CYP7B1 CL E G H | 9420 | 613812 | Bile acid synthesis defect, congenital, 3 | 613812 | C3151147 | OMIM | 1 | | 415 | 2652 | 603711 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | CYP7B1 CL E G H | 9420 | 613812 | Bile acid synthesis defect, congenital, 3 | 613812 | C3151147 | OMIM | 1 | | 415 | 2652 | 603711 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | CYP7B1 CL E G H | 9420 | 613812 | Bile acid synthesis defect, congenital, 3 | 613812 | C3151147 | OMIM | 1 | | 415 | 2652 | 603711 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | CYP7B1 CL E G H | 9420 | 613812 | Bile acid synthesis defect, congenital, 3 | 613812 | C3151147 | OMIM | 1 | | 415 | 2652 | 603711 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | CYP7B1 CL E G H | 9420 | 613812 | Bile acid synthesis defect, congenital, 3 | 613812 | C3151147 | OMIM | 1 | | 415 | 2652 | 603711 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | GLIS3 CL E G H | 169792 | 610199 | Diabetes mellitus, neonatal, with congenital hypothyroidism | 610199 | C1857775 | OMIM | 1 | | 686 | 28510 | 610192 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | GLIS3 CL E G H | 169792 | 610199 | Diabetes mellitus, neonatal, with congenital hypothyroidism | 610199 | C1857775 | OMIM | 1 | | 686 | 28510 | 610192 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | GLIS3 CL E G H | 169792 | 610199 | Diabetes mellitus, neonatal, with congenital hypothyroidism | 610199 | C1857775 | OMIM | 1 | | 686 | 28510 | 610192 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | GLIS3 CL E G H | 169792 | 610199 | Diabetes mellitus, neonatal, with congenital hypothyroidism | 610199 | C1857775 | OMIM | 1 | | 686 | 28510 | 610192 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | GLIS3 CL E G H | 169792 | 610199 | Diabetes mellitus, neonatal, with congenital hypothyroidism | 610199 | C1857775 | OMIM | 1 | | 686 | 28510 | 610192 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | GLIS3 CL E G H | 169792 | 610199 | Diabetes mellitus, neonatal, with congenital hypothyroidism | 610199 | C1857775 | OMIM | 1 | | 686 | 28510 | 610192 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | GLIS3 CL E G H | 169792 | 610199 | Diabetes mellitus, neonatal, with congenital hypothyroidism | 610199 | C1857775 | OMIM | 1 | | 686 | 28510 | 610192 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | GUSB CL E G H | 2990 | 584 | Al Gazali Donnai Mueller syndrome | | | ORPHA | 1 | | 414 | 4696 | 611499 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | GUSB CL E G H | 2990 | 584 | Al Gazali Donnai Mueller syndrome | | | ORPHA | 1 | | 414 | 4696 | 611499 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | GUSB CL E G H | 2990 | 584 | Al Gazali Donnai Mueller syndrome | | | ORPHA | 1 | | 414 | 4696 | 611499 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | GUSB CL E G H | 2990 | 584 | Al Gazali Donnai Mueller syndrome | | | ORPHA | 1 | | 414 | 4696 | 611499 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | GUSB CL E G H | 2990 | 584 | Al Gazali Donnai Mueller syndrome | | | ORPHA | 1 | | 414 | 4696 | 611499 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | GUSB CL E G H | 2990 | 584 | Al Gazali Donnai Mueller syndrome | | | ORPHA | 1 | | 414 | 4696 | 611499 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | GUSB CL E G H | 2990 | 584 | Al Gazali Donnai Mueller syndrome | | | ORPHA | 1 | | 414 | 4696 | 611499 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | PGM1 CL E G H | 5236 | 614921 | Congenital disorder of glycosylation type 1t | 614921 | C2752015 | OMIM | 1 | | 413 | 8905 | 171900 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | PGM1 CL E G H | 5236 | 614921 | Congenital disorder of glycosylation type 1t | 614921 | C2752015 | OMIM | 1 | | 413 | 8905 | 171900 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | PGM1 CL E G H | 5236 | 614921 | Congenital disorder of glycosylation type 1t | 614921 | C2752015 | OMIM | 1 | | 413 | 8905 | 171900 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | PGM1 CL E G H | 5236 | 614921 | Congenital disorder of glycosylation type 1t | 614921 | C2752015 | OMIM | 1 | | 413 | 8905 | 171900 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | PGM1 CL E G H | 5236 | 614921 | Congenital disorder of glycosylation type 1t | 614921 | C2752015 | OMIM | 1 | | 413 | 8905 | 171900 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | PGM1 CL E G H | 5236 | 614921 | Congenital disorder of glycosylation type 1t | 614921 | C2752015 | OMIM | 1 | | 413 | 8905 | 171900 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | PGM1 CL E G H | 5236 | 614921 | Congenital disorder of glycosylation type 1t | 614921 | C2752015 | OMIM | 1 | | 413 | 8905 | 171900 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | SERPINA1 CL E G H | 5265 | 60 | | | | ORPHA | 1 | | 423 | 8941 | 107400 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | SERPINA1 CL E G H | 5265 | 60 | | | | ORPHA | 1 | | 423 | 8941 | 107400 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | SERPINA1 CL E G H | 5265 | 60 | | | | ORPHA | 1 | | 423 | 8941 | 107400 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | SERPINA1 CL E G H | 5265 | 60 | | | | ORPHA | 1 | | 423 | 8941 | 107400 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | SERPINA1 CL E G H | 5265 | 60 | | | | ORPHA | 1 | | 423 | 8941 | 107400 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | SERPINA1 CL E G H | 5265 | 60 | | | | ORPHA | 1 | | 423 | 8941 | 107400 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | SERPINA1 CL E G H | 5265 | 60 | | | | ORPHA | 1 | | 423 | 8941 | 107400 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | SHPK CL E G H | 23729 | 440713 | | | | ORPHA | 1 | | 232 | 1492 | 605060 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | SHPK CL E G H | 23729 | 440713 | | | | ORPHA | 1 | | 232 | 1492 | 605060 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | SHPK CL E G H | 23729 | 440713 | | | | ORPHA | 1 | | 232 | 1492 | 605060 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | SHPK CL E G H | 23729 | 440713 | | | | ORPHA | 1 | | 232 | 1492 | 605060 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | SHPK CL E G H | 23729 | 440713 | | | | ORPHA | 1 | | 232 | 1492 | 605060 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | SHPK CL E G H | 23729 | 440713 | | | | ORPHA | 1 | | 232 | 1492 | 605060 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | SHPK CL E G H | 23729 | 440713 | | | | ORPHA | 1 | | 232 | 1492 | 605060 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | SKIV2L CL E G H | 6499 | 614602 | Trichohepatoenteric syndrome 2 | 614602 | C3281289 | OMIM | 1 | | | 10898 | 600478 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | SKIV2L CL E G H | 6499 | 614602 | Trichohepatoenteric syndrome 2 | 614602 | C3281289 | OMIM | 1 | | | 10898 | 600478 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | SKIV2L CL E G H | 6499 | 614602 | Trichohepatoenteric syndrome 2 | 614602 | C3281289 | OMIM | 1 | | | 10898 | 600478 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | SKIV2L CL E G H | 6499 | 614602 | Trichohepatoenteric syndrome 2 | 614602 | C3281289 | OMIM | 1 | | | 10898 | 600478 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | SKIV2L CL E G H | 6499 | 614602 | Trichohepatoenteric syndrome 2 | 614602 | C3281289 | OMIM | 1 | | | 10898 | 600478 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | SKIV2L CL E G H | 6499 | 614602 | Trichohepatoenteric syndrome 2 | 614602 | C3281289 | OMIM | 1 | | | 10898 | 600478 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | SKIV2L CL E G H | 6499 | 614602 | Trichohepatoenteric syndrome 2 | 614602 | C3281289 | OMIM | 1 | | | 10898 | 600478 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | TPP2 CL E G H | 7174 | 444463 | | | | ORPHA | 1 | | 625 | 12016 | 190470 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | TPP2 CL E G H | 7174 | 444463 | | | | ORPHA | 1 | | 625 | 12016 | 190470 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | TPP2 CL E G H | 7174 | 444463 | | | | ORPHA | 1 | | 625 | 12016 | 190470 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | TPP2 CL E G H | 7174 | 444463 | | | | ORPHA | 1 | | 625 | 12016 | 190470 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | TPP2 CL E G H | 7174 | 444463 | | | | ORPHA | 1 | | 625 | 12016 | 190470 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | TPP2 CL E G H | 7174 | 444463 | | | | ORPHA | 1 | | 625 | 12016 | 190470 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | TPP2 CL E G H | 7174 | 444463 | | | | ORPHA | 1 | | 625 | 12016 | 190470 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | ATP7A CL E G H | 538 | 198 | | | | ORPHA | 1 | | 1751 | 869 | 300011 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | ATP7A CL E G H | 538 | 198 | | | | ORPHA | 1 | | 1751 | 869 | 300011 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | ATP7A CL E G H | 538 | 198 | | | | ORPHA | 1 | | 1751 | 869 | 300011 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | ATP7A CL E G H | 538 | 198 | | | | ORPHA | 1 | | 1751 | 869 | 300011 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | C1S CL E G H | 716 | 613783 | Complement component c1s deficiency | 613783 | C3151078 | OMIM | 1 | | 388 | 1247 | 120580 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | C1S CL E G H | 716 | 613783 | Complement component c1s deficiency | 613783 | C3151078 | OMIM | 1 | | 388 | 1247 | 120580 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | C1S CL E G H | 716 | 613783 | Complement component c1s deficiency | 613783 | C3151078 | OMIM | 1 | | 388 | 1247 | 120580 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | C1S CL E G H | 716 | 613783 | Complement component c1s deficiency | 613783 | C3151078 | OMIM | 1 | | 388 | 1247 | 120580 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | CYP7A1 CL E G H | 1581 | 209902 | | | | ORPHA | 1 | | 145 | 2651 | 118455 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | CYP7A1 CL E G H | 1581 | 209902 | | | | ORPHA | 1 | | 145 | 2651 | 118455 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | CYP7A1 CL E G H | 1581 | 209902 | | | | ORPHA | 1 | | 145 | 2651 | 118455 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | CYP7A1 CL E G H | 1581 | 209902 | | | | ORPHA | 1 | | 145 | 2651 | 118455 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | CYP7B1 CL E G H | 9420 | 613812 | Bile acid synthesis defect, congenital, 3 | 613812 | C3151147 | OMIM | 1 | | 415 | 2652 | 603711 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | CYP7B1 CL E G H | 9420 | 613812 | Bile acid synthesis defect, congenital, 3 | 613812 | C3151147 | OMIM | 1 | | 415 | 2652 | 603711 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | CYP7B1 CL E G H | 9420 | 613812 | Bile acid synthesis defect, congenital, 3 | 613812 | C3151147 | OMIM | 1 | | 415 | 2652 | 603711 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | CYP7B1 CL E G H | 9420 | 613812 | Bile acid synthesis defect, congenital, 3 | 613812 | C3151147 | OMIM | 1 | | 415 | 2652 | 603711 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | GLIS3 CL E G H | 169792 | 610199 | Diabetes mellitus, neonatal, with congenital hypothyroidism | 610199 | C1857775 | OMIM | 1 | | 686 | 28510 | 610192 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | GLIS3 CL E G H | 169792 | 610199 | Diabetes mellitus, neonatal, with congenital hypothyroidism | 610199 | C1857775 | OMIM | 1 | | 686 | 28510 | 610192 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | GLIS3 CL E G H | 169792 | 610199 | Diabetes mellitus, neonatal, with congenital hypothyroidism | 610199 | C1857775 | OMIM | 1 | | 686 | 28510 | 610192 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | GLIS3 CL E G H | 169792 | 610199 | Diabetes mellitus, neonatal, with congenital hypothyroidism | 610199 | C1857775 | OMIM | 1 | | 686 | 28510 | 610192 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | GUSB CL E G H | 2990 | 584 | Al Gazali Donnai Mueller syndrome | | | ORPHA | 1 | | 414 | 4696 | 611499 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | GUSB CL E G H | 2990 | 584 | Al Gazali Donnai Mueller syndrome | | | ORPHA | 1 | | 414 | 4696 | 611499 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | GUSB CL E G H | 2990 | 584 | Al Gazali Donnai Mueller syndrome | | | ORPHA | 1 | | 414 | 4696 | 611499 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | GUSB CL E G H | 2990 | 584 | Al Gazali Donnai Mueller syndrome | | | ORPHA | 1 | | 414 | 4696 | 611499 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | PGM1 CL E G H | 5236 | 614921 | Congenital disorder of glycosylation type 1t | 614921 | C2752015 | OMIM | 1 | | 413 | 8905 | 171900 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | PGM1 CL E G H | 5236 | 614921 | Congenital disorder of glycosylation type 1t | 614921 | C2752015 | OMIM | 1 | | 413 | 8905 | 171900 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | PGM1 CL E G H | 5236 | 614921 | Congenital disorder of glycosylation type 1t | 614921 | C2752015 | OMIM | 1 | | 413 | 8905 | 171900 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | PGM1 CL E G H | 5236 | 614921 | Congenital disorder of glycosylation type 1t | 614921 | C2752015 | OMIM | 1 | | 413 | 8905 | 171900 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | SERPINA1 CL E G H | 5265 | 60 | | | | ORPHA | 1 | | 423 | 8941 | 107400 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | SERPINA1 CL E G H | 5265 | 60 | | | | ORPHA | 1 | | 423 | 8941 | 107400 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | SERPINA1 CL E G H | 5265 | 60 | | | | ORPHA | 1 | | 423 | 8941 | 107400 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | SERPINA1 CL E G H | 5265 | 60 | | | | ORPHA | 1 | | 423 | 8941 | 107400 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | SHPK CL E G H | 23729 | 440713 | | | | ORPHA | 1 | | 232 | 1492 | 605060 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | SHPK CL E G H | 23729 | 440713 | | | | ORPHA | 1 | | 232 | 1492 | 605060 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | SHPK CL E G H | 23729 | 440713 | | | | ORPHA | 1 | | 232 | 1492 | 605060 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | SHPK CL E G H | 23729 | 440713 | | | | ORPHA | 1 | | 232 | 1492 | 605060 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | SKIV2L CL E G H | 6499 | 614602 | Trichohepatoenteric syndrome 2 | 614602 | C3281289 | OMIM | 1 | | | 10898 | 600478 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | SKIV2L CL E G H | 6499 | 614602 | Trichohepatoenteric syndrome 2 | 614602 | C3281289 | OMIM | 1 | | | 10898 | 600478 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | SKIV2L CL E G H | 6499 | 614602 | Trichohepatoenteric syndrome 2 | 614602 | C3281289 | OMIM | 1 | | | 10898 | 600478 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | SKIV2L CL E G H | 6499 | 614602 | Trichohepatoenteric syndrome 2 | 614602 | C3281289 | OMIM | 1 | | | 10898 | 600478 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | TPP2 CL E G H | 7174 | 444463 | | | | ORPHA | 1 | | 625 | 12016 | 190470 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | TPP2 CL E G H | 7174 | 444463 | | | | ORPHA | 1 | | 625 | 12016 | 190470 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | TPP2 CL E G H | 7174 | 444463 | | | | ORPHA | 1 | | 625 | 12016 | 190470 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | TPP2 CL E G H | 7174 | 444463 | | | | ORPHA | 1 | | 625 | 12016 | 190470 |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0012115 | HP:0012115 | Hepatitis | 0 | BLNK CL E G H | 29760 | 33110 | | | | ORPHA | 0 | | 296 | 14211 | 604515 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | BTK CL E G H | 695 | 47 | | | | ORPHA | 0 | | 675 | 1133 | 300300 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CD79A CL E G H | 973 | 33110 | | | | ORPHA | 0 | | 150 | 1698 | 112205 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CD79B CL E G H | 974 | 33110 | | | | ORPHA | 0 | | 161 | 1699 | 147245 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | CLEC7A CL E G H | 64581 | 1334 | | | | ORPHA | 0 | | 57 | 14558 | 606264 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | GPR35 CL E G H | 2859 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 139 | 4492 | 602646 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IGHM CL E G H | 3507 | 33110 | | | | ORPHA | 0 | | 83 | 5541 | 147020 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IGLL1 CL E G H | 3543 | 33110 | | | | ORPHA | 0 | | 310 | 5870 | 146770 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 0 | | 34 | 5969 | 161560 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 0 | | 465 | 5971 | 601604 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IL17F CL E G H | 112744 | 1334 | | | | ORPHA | 0 | | 132 | 16404 | 606496 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IL17RA CL E G H | 23765 | 1334 | | | | ORPHA | 0 | | 888 | 5985 | 605461 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IL17RC CL E G H | 84818 | 1334 | | | | ORPHA | 0 | | 582 | 18358 | 610925 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 0 | | 65 | 6120 | 607218 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | LRRC8A CL E G H | 56262 | 33110 | | | | ORPHA | 0 | | 321 | 19027 | 608360 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 0 | | 181 | 14668 | 618104 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | MST1 CL E G H | 4485 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 57 | 7380 | 142408 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | PIEZO1 CL E G H | 9780 | 194380 | Xerocytosis | 194380 | C0272051 | OMIM | 0 | | 1433 | 28993 | 611184 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | PIK3R1 CL E G H | 5295 | 33110 | | | | ORPHA | 0 | | 457 | 8979 | 171833 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 0 | | 39 | 9211 | 601206 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 0 | | 34 | 11242 | 606802 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | STAT1 CL E G H | 6772 | 391487 | | | | ORPHA | 0 | | 557 | 11362 | 600555 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TBX19 CL E G H | 9095 | 199296 | | | | ORPHA | 0 | | 165 | 11596 | 604614 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TCF3 CL E G H | 6929 | 33110 | | | | ORPHA | 0 | | 744 | 11633 | 147141 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TCF4 CL E G H | 6925 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 1069 | 11634 | 602272 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 0 | | 50 | 11931 | 604052 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 0 | | 575 | 17103 | 610032 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TRAF3IP2 CL E G H | 10758 | 1334 | | | | ORPHA | 0 | | 246 | 1343 | 607043 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | TTC7A CL E G H | 57217 | 436252 | | | | ORPHA | 0 | | 927 | 19750 | 609332 |
HP:0012115 | HP:0012115 | Hepatitis | 0 | XIAP CL E G H | 331 | 300635 | Lymphoproliferative syndrome 2, X-linked | 300635 | C1845076 | OMIM | 0 | | 502 | 592 | 300079 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | BLNK CL E G H | 29760 | 33110 | | | | ORPHA | 0 | | 296 | 14211 | 604515 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | BLNK CL E G H | 29760 | 33110 | | | | ORPHA | 0 | | 296 | 14211 | 604515 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | BLNK CL E G H | 29760 | 33110 | | | | ORPHA | 0 | | 296 | 14211 | 604515 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | BLNK CL E G H | 29760 | 33110 | | | | ORPHA | 0 | | 296 | 14211 | 604515 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | BLNK CL E G H | 29760 | 33110 | | | | ORPHA | 0 | | 296 | 14211 | 604515 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | BLNK CL E G H | 29760 | 33110 | | | | ORPHA | 0 | | 296 | 14211 | 604515 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | BLNK CL E G H | 29760 | 33110 | | | | ORPHA | 0 | | 296 | 14211 | 604515 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | BTK CL E G H | 695 | 47 | | | | ORPHA | 0 | | 675 | 1133 | 300300 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | BTK CL E G H | 695 | 47 | | | | ORPHA | 0 | | 675 | 1133 | 300300 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | BTK CL E G H | 695 | 47 | | | | ORPHA | 0 | | 675 | 1133 | 300300 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | BTK CL E G H | 695 | 47 | | | | ORPHA | 0 | | 675 | 1133 | 300300 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | BTK CL E G H | 695 | 47 | | | | ORPHA | 0 | | 675 | 1133 | 300300 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | BTK CL E G H | 695 | 47 | | | | ORPHA | 0 | | 675 | 1133 | 300300 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | BTK CL E G H | 695 | 47 | | | | ORPHA | 0 | | 675 | 1133 | 300300 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | CD79A CL E G H | 973 | 33110 | | | | ORPHA | 0 | | 150 | 1698 | 112205 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | CD79A CL E G H | 973 | 33110 | | | | ORPHA | 0 | | 150 | 1698 | 112205 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | CD79A CL E G H | 973 | 33110 | | | | ORPHA | 0 | | 150 | 1698 | 112205 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | CD79A CL E G H | 973 | 33110 | | | | ORPHA | 0 | | 150 | 1698 | 112205 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | CD79A CL E G H | 973 | 33110 | | | | ORPHA | 0 | | 150 | 1698 | 112205 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | CD79A CL E G H | 973 | 33110 | | | | ORPHA | 0 | | 150 | 1698 | 112205 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | CD79A CL E G H | 973 | 33110 | | | | ORPHA | 0 | | 150 | 1698 | 112205 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | CD79B CL E G H | 974 | 33110 | | | | ORPHA | 0 | | 161 | 1699 | 147245 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | CD79B CL E G H | 974 | 33110 | | | | ORPHA | 0 | | 161 | 1699 | 147245 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | CD79B CL E G H | 974 | 33110 | | | | ORPHA | 0 | | 161 | 1699 | 147245 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | CD79B CL E G H | 974 | 33110 | | | | ORPHA | 0 | | 161 | 1699 | 147245 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | CD79B CL E G H | 974 | 33110 | | | | ORPHA | 0 | | 161 | 1699 | 147245 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | CD79B CL E G H | 974 | 33110 | | | | ORPHA | 0 | | 161 | 1699 | 147245 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | CD79B CL E G H | 974 | 33110 | | | | ORPHA | 0 | | 161 | 1699 | 147245 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | CLEC7A CL E G H | 64581 | 1334 | | | | ORPHA | 0 | | 57 | 14558 | 606264 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | CLEC7A CL E G H | 64581 | 1334 | | | | ORPHA | 0 | | 57 | 14558 | 606264 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | CLEC7A CL E G H | 64581 | 1334 | | | | ORPHA | 0 | | 57 | 14558 | 606264 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | CLEC7A CL E G H | 64581 | 1334 | | | | ORPHA | 0 | | 57 | 14558 | 606264 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | CLEC7A CL E G H | 64581 | 1334 | | | | ORPHA | 0 | | 57 | 14558 | 606264 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | CLEC7A CL E G H | 64581 | 1334 | | | | ORPHA | 0 | | 57 | 14558 | 606264 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | CLEC7A CL E G H | 64581 | 1334 | | | | ORPHA | 0 | | 57 | 14558 | 606264 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | GPR35 CL E G H | 2859 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 139 | 4492 | 602646 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | GPR35 CL E G H | 2859 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 139 | 4492 | 602646 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | GPR35 CL E G H | 2859 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 139 | 4492 | 602646 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | GPR35 CL E G H | 2859 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 139 | 4492 | 602646 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | GPR35 CL E G H | 2859 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 139 | 4492 | 602646 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | GPR35 CL E G H | 2859 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 139 | 4492 | 602646 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | GPR35 CL E G H | 2859 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 139 | 4492 | 602646 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | IGHM CL E G H | 3507 | 33110 | | | | ORPHA | 0 | | 83 | 5541 | 147020 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | IGHM CL E G H | 3507 | 33110 | | | | ORPHA | 0 | | 83 | 5541 | 147020 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | IGHM CL E G H | 3507 | 33110 | | | | ORPHA | 0 | | 83 | 5541 | 147020 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | IGHM CL E G H | 3507 | 33110 | | | | ORPHA | 0 | | 83 | 5541 | 147020 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | IGHM CL E G H | 3507 | 33110 | | | | ORPHA | 0 | | 83 | 5541 | 147020 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | IGHM CL E G H | 3507 | 33110 | | | | ORPHA | 0 | | 83 | 5541 | 147020 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | IGHM CL E G H | 3507 | 33110 | | | | ORPHA | 0 | | 83 | 5541 | 147020 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | IGLL1 CL E G H | 3543 | 33110 | | | | ORPHA | 0 | | 310 | 5870 | 146770 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | IGLL1 CL E G H | 3543 | 33110 | | | | ORPHA | 0 | | 310 | 5870 | 146770 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | IGLL1 CL E G H | 3543 | 33110 | | | | ORPHA | 0 | | 310 | 5870 | 146770 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | IGLL1 CL E G H | 3543 | 33110 | | | | ORPHA | 0 | | 310 | 5870 | 146770 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | IGLL1 CL E G H | 3543 | 33110 | | | | ORPHA | 0 | | 310 | 5870 | 146770 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | IGLL1 CL E G H | 3543 | 33110 | | | | ORPHA | 0 | | 310 | 5870 | 146770 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | IGLL1 CL E G H | 3543 | 33110 | | | | ORPHA | 0 | | 310 | 5870 | 146770 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 0 | | 34 | 5969 | 161560 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 0 | | 34 | 5969 | 161560 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 0 | | 34 | 5969 | 161560 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 0 | | 34 | 5969 | 161560 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 0 | | 34 | 5969 | 161560 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 0 | | 34 | 5969 | 161560 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 0 | | 34 | 5969 | 161560 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 0 | | 465 | 5971 | 601604 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 0 | | 465 | 5971 | 601604 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 0 | | 465 | 5971 | 601604 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 0 | | 465 | 5971 | 601604 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 0 | | 465 | 5971 | 601604 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 0 | | 465 | 5971 | 601604 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 0 | | 465 | 5971 | 601604 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | IL17F CL E G H | 112744 | 1334 | | | | ORPHA | 0 | | 132 | 16404 | 606496 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | IL17F CL E G H | 112744 | 1334 | | | | ORPHA | 0 | | 132 | 16404 | 606496 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | IL17F CL E G H | 112744 | 1334 | | | | ORPHA | 0 | | 132 | 16404 | 606496 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | IL17F CL E G H | 112744 | 1334 | | | | ORPHA | 0 | | 132 | 16404 | 606496 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | IL17F CL E G H | 112744 | 1334 | | | | ORPHA | 0 | | 132 | 16404 | 606496 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | IL17F CL E G H | 112744 | 1334 | | | | ORPHA | 0 | | 132 | 16404 | 606496 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | IL17F CL E G H | 112744 | 1334 | | | | ORPHA | 0 | | 132 | 16404 | 606496 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | IL17RA CL E G H | 23765 | 1334 | | | | ORPHA | 0 | | 888 | 5985 | 605461 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | IL17RA CL E G H | 23765 | 1334 | | | | ORPHA | 0 | | 888 | 5985 | 605461 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | IL17RA CL E G H | 23765 | 1334 | | | | ORPHA | 0 | | 888 | 5985 | 605461 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | IL17RA CL E G H | 23765 | 1334 | | | | ORPHA | 0 | | 888 | 5985 | 605461 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | IL17RA CL E G H | 23765 | 1334 | | | | ORPHA | 0 | | 888 | 5985 | 605461 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | IL17RA CL E G H | 23765 | 1334 | | | | ORPHA | 0 | | 888 | 5985 | 605461 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | IL17RA CL E G H | 23765 | 1334 | | | | ORPHA | 0 | | 888 | 5985 | 605461 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | IL17RC CL E G H | 84818 | 1334 | | | | ORPHA | 0 | | 582 | 18358 | 610925 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | IL17RC CL E G H | 84818 | 1334 | | | | ORPHA | 0 | | 582 | 18358 | 610925 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | IL17RC CL E G H | 84818 | 1334 | | | | ORPHA | 0 | | 582 | 18358 | 610925 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | IL17RC CL E G H | 84818 | 1334 | | | | ORPHA | 0 | | 582 | 18358 | 610925 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | IL17RC CL E G H | 84818 | 1334 | | | | ORPHA | 0 | | 582 | 18358 | 610925 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | IL17RC CL E G H | 84818 | 1334 | | | | ORPHA | 0 | | 582 | 18358 | 610925 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | IL17RC CL E G H | 84818 | 1334 | | | | ORPHA | 0 | | 582 | 18358 | 610925 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 0 | | 65 | 6120 | 607218 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 0 | | 65 | 6120 | 607218 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 0 | | 65 | 6120 | 607218 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 0 | | 65 | 6120 | 607218 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 0 | | 65 | 6120 | 607218 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 0 | | 65 | 6120 | 607218 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 0 | | 65 | 6120 | 607218 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | LRRC8A CL E G H | 56262 | 33110 | | | | ORPHA | 0 | | 321 | 19027 | 608360 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | LRRC8A CL E G H | 56262 | 33110 | | | | ORPHA | 0 | | 321 | 19027 | 608360 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | LRRC8A CL E G H | 56262 | 33110 | | | | ORPHA | 0 | | 321 | 19027 | 608360 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | LRRC8A CL E G H | 56262 | 33110 | | | | ORPHA | 0 | | 321 | 19027 | 608360 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | LRRC8A CL E G H | 56262 | 33110 | | | | ORPHA | 0 | | 321 | 19027 | 608360 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | LRRC8A CL E G H | 56262 | 33110 | | | | ORPHA | 0 | | 321 | 19027 | 608360 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | LRRC8A CL E G H | 56262 | 33110 | | | | ORPHA | 0 | | 321 | 19027 | 608360 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 0 | | 181 | 14668 | 618104 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 0 | | 181 | 14668 | 618104 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 0 | | 181 | 14668 | 618104 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 0 | | 181 | 14668 | 618104 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 0 | | 181 | 14668 | 618104 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 0 | | 181 | 14668 | 618104 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 0 | | 181 | 14668 | 618104 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | MST1 CL E G H | 4485 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 57 | 7380 | 142408 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | MST1 CL E G H | 4485 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 57 | 7380 | 142408 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | MST1 CL E G H | 4485 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 57 | 7380 | 142408 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | MST1 CL E G H | 4485 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 57 | 7380 | 142408 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | MST1 CL E G H | 4485 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 57 | 7380 | 142408 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | MST1 CL E G H | 4485 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 57 | 7380 | 142408 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | MST1 CL E G H | 4485 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 57 | 7380 | 142408 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | PIEZO1 CL E G H | 9780 | 194380 | Xerocytosis | 194380 | C0272051 | OMIM | 0 | | 1433 | 28993 | 611184 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | PIEZO1 CL E G H | 9780 | 194380 | Xerocytosis | 194380 | C0272051 | OMIM | 0 | | 1433 | 28993 | 611184 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | PIEZO1 CL E G H | 9780 | 194380 | Xerocytosis | 194380 | C0272051 | OMIM | 0 | | 1433 | 28993 | 611184 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | PIEZO1 CL E G H | 9780 | 194380 | Xerocytosis | 194380 | C0272051 | OMIM | 0 | | 1433 | 28993 | 611184 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | PIEZO1 CL E G H | 9780 | 194380 | Xerocytosis | 194380 | C0272051 | OMIM | 0 | | 1433 | 28993 | 611184 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | PIEZO1 CL E G H | 9780 | 194380 | Xerocytosis | 194380 | C0272051 | OMIM | 0 | | 1433 | 28993 | 611184 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | PIEZO1 CL E G H | 9780 | 194380 | Xerocytosis | 194380 | C0272051 | OMIM | 0 | | 1433 | 28993 | 611184 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | PIK3R1 CL E G H | 5295 | 33110 | | | | ORPHA | 0 | | 457 | 8979 | 171833 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | PIK3R1 CL E G H | 5295 | 33110 | | | | ORPHA | 0 | | 457 | 8979 | 171833 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | PIK3R1 CL E G H | 5295 | 33110 | | | | ORPHA | 0 | | 457 | 8979 | 171833 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | PIK3R1 CL E G H | 5295 | 33110 | | | | ORPHA | 0 | | 457 | 8979 | 171833 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | PIK3R1 CL E G H | 5295 | 33110 | | | | ORPHA | 0 | | 457 | 8979 | 171833 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | PIK3R1 CL E G H | 5295 | 33110 | | | | ORPHA | 0 | | 457 | 8979 | 171833 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | PIK3R1 CL E G H | 5295 | 33110 | | | | ORPHA | 0 | | 457 | 8979 | 171833 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 0 | | 39 | 9211 | 601206 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 0 | | 39 | 9211 | 601206 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 0 | | 39 | 9211 | 601206 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 0 | | 39 | 9211 | 601206 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 0 | | 39 | 9211 | 601206 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 0 | | 39 | 9211 | 601206 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 0 | | 39 | 9211 | 601206 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 0 | | 34 | 11242 | 606802 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 0 | | 34 | 11242 | 606802 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 0 | | 34 | 11242 | 606802 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 0 | | 34 | 11242 | 606802 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 0 | | 34 | 11242 | 606802 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 0 | | 34 | 11242 | 606802 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 0 | | 34 | 11242 | 606802 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | STAT1 CL E G H | 6772 | 391487 | | | | ORPHA | 0 | | 557 | 11362 | 600555 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | STAT1 CL E G H | 6772 | 391487 | | | | ORPHA | 0 | | 557 | 11362 | 600555 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | STAT1 CL E G H | 6772 | 391487 | | | | ORPHA | 0 | | 557 | 11362 | 600555 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | STAT1 CL E G H | 6772 | 391487 | | | | ORPHA | 0 | | 557 | 11362 | 600555 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | STAT1 CL E G H | 6772 | 391487 | | | | ORPHA | 0 | | 557 | 11362 | 600555 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | STAT1 CL E G H | 6772 | 391487 | | | | ORPHA | 0 | | 557 | 11362 | 600555 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | STAT1 CL E G H | 6772 | 391487 | | | | ORPHA | 0 | | 557 | 11362 | 600555 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | TBX19 CL E G H | 9095 | 199296 | | | | ORPHA | 0 | | 165 | 11596 | 604614 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | TBX19 CL E G H | 9095 | 199296 | | | | ORPHA | 0 | | 165 | 11596 | 604614 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | TBX19 CL E G H | 9095 | 199296 | | | | ORPHA | 0 | | 165 | 11596 | 604614 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | TBX19 CL E G H | 9095 | 199296 | | | | ORPHA | 0 | | 165 | 11596 | 604614 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | TBX19 CL E G H | 9095 | 199296 | | | | ORPHA | 0 | | 165 | 11596 | 604614 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | TBX19 CL E G H | 9095 | 199296 | | | | ORPHA | 0 | | 165 | 11596 | 604614 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | TBX19 CL E G H | 9095 | 199296 | | | | ORPHA | 0 | | 165 | 11596 | 604614 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | TCF3 CL E G H | 6929 | 33110 | | | | ORPHA | 0 | | 744 | 11633 | 147141 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | TCF3 CL E G H | 6929 | 33110 | | | | ORPHA | 0 | | 744 | 11633 | 147141 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | TCF3 CL E G H | 6929 | 33110 | | | | ORPHA | 0 | | 744 | 11633 | 147141 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | TCF3 CL E G H | 6929 | 33110 | | | | ORPHA | 0 | | 744 | 11633 | 147141 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | TCF3 CL E G H | 6929 | 33110 | | | | ORPHA | 0 | | 744 | 11633 | 147141 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | TCF3 CL E G H | 6929 | 33110 | | | | ORPHA | 0 | | 744 | 11633 | 147141 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | TCF3 CL E G H | 6929 | 33110 | | | | ORPHA | 0 | | 744 | 11633 | 147141 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | TCF4 CL E G H | 6925 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 1069 | 11634 | 602272 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | TCF4 CL E G H | 6925 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 1069 | 11634 | 602272 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | TCF4 CL E G H | 6925 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 1069 | 11634 | 602272 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | TCF4 CL E G H | 6925 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 1069 | 11634 | 602272 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | TCF4 CL E G H | 6925 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 1069 | 11634 | 602272 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | TCF4 CL E G H | 6925 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 1069 | 11634 | 602272 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | TCF4 CL E G H | 6925 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 1069 | 11634 | 602272 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 0 | | 50 | 11931 | 604052 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 0 | | 50 | 11931 | 604052 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 0 | | 50 | 11931 | 604052 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 0 | | 50 | 11931 | 604052 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 0 | | 50 | 11931 | 604052 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 0 | | 50 | 11931 | 604052 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 0 | | 50 | 11931 | 604052 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 0 | | 575 | 17103 | 610032 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 0 | | 575 | 17103 | 610032 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 0 | | 575 | 17103 | 610032 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 0 | | 575 | 17103 | 610032 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 0 | | 575 | 17103 | 610032 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 0 | | 575 | 17103 | 610032 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 0 | | 575 | 17103 | 610032 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | TRAF3IP2 CL E G H | 10758 | 1334 | | | | ORPHA | 0 | | 246 | 1343 | 607043 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | TRAF3IP2 CL E G H | 10758 | 1334 | | | | ORPHA | 0 | | 246 | 1343 | 607043 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | TRAF3IP2 CL E G H | 10758 | 1334 | | | | ORPHA | 0 | | 246 | 1343 | 607043 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | TRAF3IP2 CL E G H | 10758 | 1334 | | | | ORPHA | 0 | | 246 | 1343 | 607043 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | TRAF3IP2 CL E G H | 10758 | 1334 | | | | ORPHA | 0 | | 246 | 1343 | 607043 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | TRAF3IP2 CL E G H | 10758 | 1334 | | | | ORPHA | 0 | | 246 | 1343 | 607043 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | TRAF3IP2 CL E G H | 10758 | 1334 | | | | ORPHA | 0 | | 246 | 1343 | 607043 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | TTC7A CL E G H | 57217 | 436252 | | | | ORPHA | 0 | | 927 | 19750 | 609332 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | TTC7A CL E G H | 57217 | 436252 | | | | ORPHA | 0 | | 927 | 19750 | 609332 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | TTC7A CL E G H | 57217 | 436252 | | | | ORPHA | 0 | | 927 | 19750 | 609332 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | TTC7A CL E G H | 57217 | 436252 | | | | ORPHA | 0 | | 927 | 19750 | 609332 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | TTC7A CL E G H | 57217 | 436252 | | | | ORPHA | 0 | | 927 | 19750 | 609332 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | TTC7A CL E G H | 57217 | 436252 | | | | ORPHA | 0 | | 927 | 19750 | 609332 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | TTC7A CL E G H | 57217 | 436252 | | | | ORPHA | 0 | | 927 | 19750 | 609332 |
HP:0012115 | HP:0200122 | Atypical or prolonged hepatitis | 1 | XIAP CL E G H | 331 | 300635 | Lymphoproliferative syndrome 2, X-linked | 300635 | C1845076 | OMIM | 0 | | 502 | 592 | 300079 |
HP:0012115 | HP:0200084 | Giant cell hepatitis | 1 | XIAP CL E G H | 331 | 300635 | Lymphoproliferative syndrome 2, X-linked | 300635 | C1845076 | OMIM | 0 | | 502 | 592 | 300079 |
HP:0012115 | HP:0200119 | Acute hepatitis | 1 | XIAP CL E G H | 331 | 300635 | Lymphoproliferative syndrome 2, X-linked | 300635 | C1845076 | OMIM | 0 | | 502 | 592 | 300079 |
HP:0012115 | HP:0004787 | Fulminant hepatitis | 1 | XIAP CL E G H | 331 | 300635 | Lymphoproliferative syndrome 2, X-linked | 300635 | C1845076 | OMIM | 0 | | 502 | 592 | 300079 |
HP:0012115 | HP:0006562 | Viral hepatitis | 1 | XIAP CL E G H | 331 | 300635 | Lymphoproliferative syndrome 2, X-linked | 300635 | C1845076 | OMIM | 0 | | 502 | 592 | 300079 |
HP:0012115 | HP:0200123 | Chronic hepatitis | 1 | XIAP CL E G H | 331 | 300635 | Lymphoproliferative syndrome 2, X-linked | 300635 | C1845076 | OMIM | 0 | | 502 | 592 | 300079 |
HP:0012115 | HP:0032220 | Interface hepatitis | 1 | XIAP CL E G H | 331 | 300635 | Lymphoproliferative syndrome 2, X-linked | 300635 | C1845076 | OMIM | 0 | | 502 | 592 | 300079 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | BLNK CL E G H | 29760 | 33110 | | | | ORPHA | 0 | | 296 | 14211 | 604515 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | BLNK CL E G H | 29760 | 33110 | | | | ORPHA | 0 | | 296 | 14211 | 604515 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | BLNK CL E G H | 29760 | 33110 | | | | ORPHA | 0 | | 296 | 14211 | 604515 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | BLNK CL E G H | 29760 | 33110 | | | | ORPHA | 0 | | 296 | 14211 | 604515 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | BTK CL E G H | 695 | 47 | | | | ORPHA | 0 | | 675 | 1133 | 300300 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | BTK CL E G H | 695 | 47 | | | | ORPHA | 0 | | 675 | 1133 | 300300 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | BTK CL E G H | 695 | 47 | | | | ORPHA | 0 | | 675 | 1133 | 300300 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | BTK CL E G H | 695 | 47 | | | | ORPHA | 0 | | 675 | 1133 | 300300 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | CD79A CL E G H | 973 | 33110 | | | | ORPHA | 0 | | 150 | 1698 | 112205 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | CD79A CL E G H | 973 | 33110 | | | | ORPHA | 0 | | 150 | 1698 | 112205 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | CD79A CL E G H | 973 | 33110 | | | | ORPHA | 0 | | 150 | 1698 | 112205 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | CD79A CL E G H | 973 | 33110 | | | | ORPHA | 0 | | 150 | 1698 | 112205 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | CD79B CL E G H | 974 | 33110 | | | | ORPHA | 0 | | 161 | 1699 | 147245 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | CD79B CL E G H | 974 | 33110 | | | | ORPHA | 0 | | 161 | 1699 | 147245 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | CD79B CL E G H | 974 | 33110 | | | | ORPHA | 0 | | 161 | 1699 | 147245 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | CD79B CL E G H | 974 | 33110 | | | | ORPHA | 0 | | 161 | 1699 | 147245 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | CLEC7A CL E G H | 64581 | 1334 | | | | ORPHA | 0 | | 57 | 14558 | 606264 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | CLEC7A CL E G H | 64581 | 1334 | | | | ORPHA | 0 | | 57 | 14558 | 606264 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | CLEC7A CL E G H | 64581 | 1334 | | | | ORPHA | 0 | | 57 | 14558 | 606264 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | CLEC7A CL E G H | 64581 | 1334 | | | | ORPHA | 0 | | 57 | 14558 | 606264 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | GPR35 CL E G H | 2859 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 139 | 4492 | 602646 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | GPR35 CL E G H | 2859 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 139 | 4492 | 602646 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | GPR35 CL E G H | 2859 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 139 | 4492 | 602646 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | GPR35 CL E G H | 2859 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 139 | 4492 | 602646 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | IGHM CL E G H | 3507 | 33110 | | | | ORPHA | 0 | | 83 | 5541 | 147020 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | IGHM CL E G H | 3507 | 33110 | | | | ORPHA | 0 | | 83 | 5541 | 147020 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | IGHM CL E G H | 3507 | 33110 | | | | ORPHA | 0 | | 83 | 5541 | 147020 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | IGHM CL E G H | 3507 | 33110 | | | | ORPHA | 0 | | 83 | 5541 | 147020 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | IGLL1 CL E G H | 3543 | 33110 | | | | ORPHA | 0 | | 310 | 5870 | 146770 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | IGLL1 CL E G H | 3543 | 33110 | | | | ORPHA | 0 | | 310 | 5870 | 146770 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | IGLL1 CL E G H | 3543 | 33110 | | | | ORPHA | 0 | | 310 | 5870 | 146770 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | IGLL1 CL E G H | 3543 | 33110 | | | | ORPHA | 0 | | 310 | 5870 | 146770 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 0 | | 34 | 5969 | 161560 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 0 | | 34 | 5969 | 161560 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 0 | | 34 | 5969 | 161560 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 0 | | 34 | 5969 | 161560 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 0 | | 465 | 5971 | 601604 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 0 | | 465 | 5971 | 601604 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 0 | | 465 | 5971 | 601604 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 0 | | 465 | 5971 | 601604 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | IL17F CL E G H | 112744 | 1334 | | | | ORPHA | 0 | | 132 | 16404 | 606496 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | IL17F CL E G H | 112744 | 1334 | | | | ORPHA | 0 | | 132 | 16404 | 606496 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | IL17F CL E G H | 112744 | 1334 | | | | ORPHA | 0 | | 132 | 16404 | 606496 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | IL17F CL E G H | 112744 | 1334 | | | | ORPHA | 0 | | 132 | 16404 | 606496 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | IL17RA CL E G H | 23765 | 1334 | | | | ORPHA | 0 | | 888 | 5985 | 605461 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | IL17RA CL E G H | 23765 | 1334 | | | | ORPHA | 0 | | 888 | 5985 | 605461 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | IL17RA CL E G H | 23765 | 1334 | | | | ORPHA | 0 | | 888 | 5985 | 605461 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | IL17RA CL E G H | 23765 | 1334 | | | | ORPHA | 0 | | 888 | 5985 | 605461 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | IL17RC CL E G H | 84818 | 1334 | | | | ORPHA | 0 | | 582 | 18358 | 610925 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | IL17RC CL E G H | 84818 | 1334 | | | | ORPHA | 0 | | 582 | 18358 | 610925 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | IL17RC CL E G H | 84818 | 1334 | | | | ORPHA | 0 | | 582 | 18358 | 610925 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | IL17RC CL E G H | 84818 | 1334 | | | | ORPHA | 0 | | 582 | 18358 | 610925 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 0 | | 65 | 6120 | 607218 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 0 | | 65 | 6120 | 607218 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 0 | | 65 | 6120 | 607218 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 0 | | 65 | 6120 | 607218 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | LRRC8A CL E G H | 56262 | 33110 | | | | ORPHA | 0 | | 321 | 19027 | 608360 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | LRRC8A CL E G H | 56262 | 33110 | | | | ORPHA | 0 | | 321 | 19027 | 608360 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | LRRC8A CL E G H | 56262 | 33110 | | | | ORPHA | 0 | | 321 | 19027 | 608360 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | LRRC8A CL E G H | 56262 | 33110 | | | | ORPHA | 0 | | 321 | 19027 | 608360 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 0 | | 181 | 14668 | 618104 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 0 | | 181 | 14668 | 618104 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 0 | | 181 | 14668 | 618104 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 0 | | 181 | 14668 | 618104 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | MST1 CL E G H | 4485 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 57 | 7380 | 142408 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | MST1 CL E G H | 4485 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 57 | 7380 | 142408 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | MST1 CL E G H | 4485 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 57 | 7380 | 142408 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | MST1 CL E G H | 4485 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 57 | 7380 | 142408 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | PIEZO1 CL E G H | 9780 | 194380 | Xerocytosis | 194380 | C0272051 | OMIM | 0 | | 1433 | 28993 | 611184 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | PIEZO1 CL E G H | 9780 | 194380 | Xerocytosis | 194380 | C0272051 | OMIM | 0 | | 1433 | 28993 | 611184 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | PIEZO1 CL E G H | 9780 | 194380 | Xerocytosis | 194380 | C0272051 | OMIM | 0 | | 1433 | 28993 | 611184 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | PIEZO1 CL E G H | 9780 | 194380 | Xerocytosis | 194380 | C0272051 | OMIM | 0 | | 1433 | 28993 | 611184 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | PIK3R1 CL E G H | 5295 | 33110 | | | | ORPHA | 0 | | 457 | 8979 | 171833 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | PIK3R1 CL E G H | 5295 | 33110 | | | | ORPHA | 0 | | 457 | 8979 | 171833 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | PIK3R1 CL E G H | 5295 | 33110 | | | | ORPHA | 0 | | 457 | 8979 | 171833 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | PIK3R1 CL E G H | 5295 | 33110 | | | | ORPHA | 0 | | 457 | 8979 | 171833 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 0 | | 39 | 9211 | 601206 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 0 | | 39 | 9211 | 601206 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 0 | | 39 | 9211 | 601206 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 0 | | 39 | 9211 | 601206 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 0 | | 34 | 11242 | 606802 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 0 | | 34 | 11242 | 606802 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 0 | | 34 | 11242 | 606802 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 0 | | 34 | 11242 | 606802 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | STAT1 CL E G H | 6772 | 391487 | | | | ORPHA | 0 | | 557 | 11362 | 600555 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | STAT1 CL E G H | 6772 | 391487 | | | | ORPHA | 0 | | 557 | 11362 | 600555 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | STAT1 CL E G H | 6772 | 391487 | | | | ORPHA | 0 | | 557 | 11362 | 600555 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | STAT1 CL E G H | 6772 | 391487 | | | | ORPHA | 0 | | 557 | 11362 | 600555 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | TBX19 CL E G H | 9095 | 199296 | | | | ORPHA | 0 | | 165 | 11596 | 604614 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | TBX19 CL E G H | 9095 | 199296 | | | | ORPHA | 0 | | 165 | 11596 | 604614 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | TBX19 CL E G H | 9095 | 199296 | | | | ORPHA | 0 | | 165 | 11596 | 604614 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | TBX19 CL E G H | 9095 | 199296 | | | | ORPHA | 0 | | 165 | 11596 | 604614 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | TCF3 CL E G H | 6929 | 33110 | | | | ORPHA | 0 | | 744 | 11633 | 147141 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | TCF3 CL E G H | 6929 | 33110 | | | | ORPHA | 0 | | 744 | 11633 | 147141 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | TCF3 CL E G H | 6929 | 33110 | | | | ORPHA | 0 | | 744 | 11633 | 147141 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | TCF3 CL E G H | 6929 | 33110 | | | | ORPHA | 0 | | 744 | 11633 | 147141 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | TCF4 CL E G H | 6925 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 1069 | 11634 | 602272 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | TCF4 CL E G H | 6925 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 1069 | 11634 | 602272 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | TCF4 CL E G H | 6925 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 1069 | 11634 | 602272 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | TCF4 CL E G H | 6925 | 171 | Le Marec Bracq Picaud syndrome | | | ORPHA | 0 | | 1069 | 11634 | 602272 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 0 | | 50 | 11931 | 604052 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 0 | | 50 | 11931 | 604052 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 0 | | 50 | 11931 | 604052 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 0 | | 50 | 11931 | 604052 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 0 | | 575 | 17103 | 610032 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 0 | | 575 | 17103 | 610032 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 0 | | 575 | 17103 | 610032 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 0 | | 575 | 17103 | 610032 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | TRAF3IP2 CL E G H | 10758 | 1334 | | | | ORPHA | 0 | | 246 | 1343 | 607043 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | TRAF3IP2 CL E G H | 10758 | 1334 | | | | ORPHA | 0 | | 246 | 1343 | 607043 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | TRAF3IP2 CL E G H | 10758 | 1334 | | | | ORPHA | 0 | | 246 | 1343 | 607043 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | TRAF3IP2 CL E G H | 10758 | 1334 | | | | ORPHA | 0 | | 246 | 1343 | 607043 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | TTC7A CL E G H | 57217 | 436252 | | | | ORPHA | 0 | | 927 | 19750 | 609332 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | TTC7A CL E G H | 57217 | 436252 | | | | ORPHA | 0 | | 927 | 19750 | 609332 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | TTC7A CL E G H | 57217 | 436252 | | | | ORPHA | 0 | | 927 | 19750 | 609332 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | TTC7A CL E G H | 57217 | 436252 | | | | ORPHA | 0 | | 927 | 19750 | 609332 |
HP:0012115 | HP:0006572 | Subacute progressive viral hepatitis | 2 | XIAP CL E G H | 331 | 300635 | Lymphoproliferative syndrome 2, X-linked | 300635 | C1845076 | OMIM | 0 | | 502 | 592 | 300079 |
HP:0012115 | HP:0200124 | Chronic hepatitis due to cryptosporidium infection | 2 | XIAP CL E G H | 331 | 300635 | Lymphoproliferative syndrome 2, X-linked | 300635 | C1845076 | OMIM | 0 | | 502 | 592 | 300079 |
HP:0012115 | HP:0001412 | Enteroviral hepatitis | 2 | XIAP CL E G H | 331 | 300635 | Lymphoproliferative syndrome 2, X-linked | 300635 | C1845076 | OMIM | 0 | | 502 | 592 | 300079 |
HP:0012115 | HP:0200120 | Chronic active hepatitis | 2 | XIAP CL E G H | 331 | 300635 | Lymphoproliferative syndrome 2, X-linked | 300635 | C1845076 | OMIM | 0 | | 502 | 592 | 300079 |